New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Spectral Medical Inc.
EDT.TO
Shape
US Flag

TSX

Unprofitable

Unprofitable

167M

Medical - Diagnostics & Research

Next Earning date - 07 Nov 2024

167M

Medical - Diagnostics & Research

Next Earning date - 07 Nov 2024

0.59CAD
Shape-0.01 ( -1.67%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-48%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

21%

Quote Panel

Shape
Updated October 24, 2024
1W -3.28 % 1M -4.84 % 3M 13.46 % 1Y 84.37 %

Key Metrics

Shape
  • Market Cap

    166.86M


  • Shares Outstanding

    282.82M


  • Share in Float

    194.07M


  • Dividende

    0


  • Earning Date

    07 Nov 2024


  • Price Target

    0.59


  • Average Volume

    88010


  • Beta

    0.965


  • Range

    0.305-0.75


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.spectraldx.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

87.78x

P/S Ratio

-7.23x

P/B Ratio

-0.6

Debt/Equity

-973.6%

Net Margin

$-0.1

EPS

How EDT.TO compares to sector?

P/E Ratio

Relative Strength

Shape

EDT.TO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$2M

Shape410%

2025-Revenue

$0.03

Shape-91%

2025-EPS

$2M

Shape40%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

N/A

-0.01
vs -0.01

Q2.22

arrow
arrow

N/A

-0.01
vs -0.01

Q3.22

arrow
arrow

N/A

-0.01
vs -0.01

Q4.22

arrow
arrow

N/A

-0.01
vs -0.01

Q1.23

arrow
arrow

N/A

-0.01
vs -0.01

Q2.23

arrow
arrow

N/A

-0.01
vs -0.01

Q3.23

arrow
arrow

N/A

-0.01
vs -0.01

Q4.23

arrow
arrow

N/A

-0.02
vs -0.01

Q1.24

arrow
arrow

N/A

-0.01
vs -0.01

Q2.24

arrow
arrow

N/A

-0.02
vs -0.01

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

-35%

484K  vs 746K

Q2.22

arrow
arrow

-49%

286K  vs 559K

Q3.22

arrow
arrow

+63%

374K  vs 230K

Q4.22

arrow
arrow

+1%

523K  vs 517K

Q1.23

arrow
arrow

+10%

530K  vs 484K

Q2.23

arrow
arrow

+7%

306K  vs 286K

Q3.23

arrow
arrow

+6%

397K  vs 374K

Q4.23

arrow
arrow

-30%

365K  vs 523K

Q1.24

arrow
arrow

+26%

668K  vs 530K

Q2.24

arrow
arrow

+54%

471K  vs 306K

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+88%

0.88
vs 4.33

Q4.22

arrow
arrow

+95%

0.95
vs 0.88

Q1.23

arrow
arrow

+40%

0.4
vs 0.95

Q2.23

arrow
arrow

+54%

0.54
vs 0.4

Q3.23

arrow
arrow

+33%

0.33
vs 0.54

Q4.23

arrow
arrow

+40%

0.4
vs 0.33

Q1.24

arrow
arrow

+21%

0.21
vs 0.4

Q2.24

arrow
arrow

+19%

0.19
vs 0.21

Institutionnal OwnershipShape

status-upQoQ

Q2.17

arrow
arrow

1

1
vs 2

-50%

Q3.17

arrow
arrow

1

1
vs 1

NA

Q4.17

arrow
arrow

1

1
vs 1

NA

Q1.18

arrow
arrow

1

1
vs 1

NA

Q2.18

arrow
arrow

1

1
vs 1

NA

Q3.18

arrow
arrow

1

1
vs 1

NA

Q4.18

arrow
arrow

1

1
vs 1

NA

Q1.23

arrow
arrow

1

1
vs NA

NA

Earnings Growth

Latest News